Related Experiment Videos

[Activity of cefuroxime against bacterial strains isolated from acute otitis media]

M Simonet1, J L Herrmann, M Veron

  • 1Laboratoire de Microbiologie, Hôpital Necker-Enfants Malades, Paris.

Insights

Cefuroxime-axetil effectively inhibits common bacteria causing acute otitis media in children, including beta-lactamase producing strains. This study demonstrates its broad antibacterial spectrum against key pathogens like Haemophilus influenzae and Streptococcus pneumoniae.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pharmacology

Background:

  • Acute otitis media (AOM) is a common childhood infection, frequently caused by bacterial pathogens.
  • Commonly isolated bacteria include Haemophilus influenzae and Streptococcus pneumoniae, often necessitating antibiotic treatment.
  • Beta-lactam antibiotics, such as cephalosporins, are primary treatments for AOM.

Purpose of the Study:

  • To evaluate the in vitro activity of cefuroxime-axetil against bacterial strains isolated from pediatric AOM cases.
  • To determine the efficacy of cefuroxime-axetil against both beta-lactamase positive and negative strains of key pathogens.

Main Methods:

  • A collection of 210 bacterial strains from pediatric AOM otorrhoea was tested.
  • Bacterial species included Haemophilus influenzae, Streptococcus pneumoniae, Branhamella catarrhalis, Staphylococcus aureus, Enterobacteriaceae, and corynebacteria.
  • Minimal inhibitory concentrations (MICs) of cefuroxime-axetil were determined using agar dilution methods.

Main Results:

  • Cefuroxime-axetil demonstrated low MICs against Haemophilus influenzae, irrespective of beta-lactamase production (MIC50 = 1 mg/l; MIC90 = 1 mg/l).
  • Overall, 90% and 98% of the tested strains were inhibited by 1 mg/l and 4 mg/l of cefuroxime, respectively.
  • The compound showed significant activity against a broad range of AOM-associated bacteria.

Conclusions:

  • Cefuroxime-axetil possesses a suitable antibacterial spectrum for treating AOM caused by prevalent bacterial isolates.
  • Its effectiveness against beta-lactamase producing strains is particularly noteworthy for clinical application.

Related Concept Videos